Navigation Links
Pharmacyclics Reports Financial Results and Recent Developments for Fiscal Year and Fourth Quarter 2011 - Conference Call Set for Today at 4:30 PM EDT
Date:9/12/2011

l and administrative2,5062,6869,1257,561Total operating expenses12,3819,35443,60724,919Loss from operations(10,995)(6,861)(35,374)(15,612)Interest and other income (expense), net312317138Loss before benefit from income tax(10,964)(6,838)(35,203)(15,574)Benefit from income tax---550Net loss

$

  (10,964)

$(6,838)

$(35,203)

$(15,024)Basic and diluted net loss per share

$(0.18)

$(0.13)

$(0.59)

$(0.31)Shares used to compute basic and   diluted net loss per share60,96851,77159,97348,344*  Includes share-based compensation as follows:Research and development

$

1,133

$

1,400

$

5,307

$

1,998General and administrative7134922,5111,192Total

$

1,846

$

1,892

$

7,818

$

3,190Reconciliation of Selected GAAP Measures to Non-GAAP Measures (1)(unaudited; in thousands, except per share data)Three Months EndedJune 30,20112010GAAP net loss$

(10,964)

$

(6,838)Adjustments:Research & development share-based compensation(2)1,1331,400General & administrative share-based compensation(2)7134921,8461,892Non-GAAP net loss$

(9,118)

$

(4,946)Non-GAAP net loss per share$

(0.15)

$

(0.10)(1)

This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our financial statements prepared in accordance with GAAP.(2)

All share-based compensation was excluded for the non-GAAP analysis.Reconciliation of Selected GAAP Measures to Non-GAAP Measures (1)(unaudited; in thousands, except per share data)Year Ended June 30,20112010GAAP net loss$

(35,203)

$

(15,024)Adjustments:Research & development share-based compensation(2)5,3071,998General & administrative share-based compen
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pharmacyclics Announces Date of Fiscal Year End 2011 Financial Results and Conference Call
2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
3. Pharmacyclics Announces Oral Presentations and Clinical Update at Upcoming Medical Meetings
4. Pharmacyclics to Announce Third Quarter Fiscal 2011 Results and Host a Conference Call on May 4, 2011
5. Pharmacyclics to Announce Second Quarter Fiscal 2011 Results and Host a Conference Call on February 4, 2011
6. Pharmacyclics Reports Updated Clinical Results from its Phase IA Trial of its First in Human Btk-Inhibitor PCI-32765
7. Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765
8. Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010
9. Pharmacyclics Announces Date of Fiscal Year End 2010 Financial Results and Conference Call and Presentation at Stifel Nicolaus Healthcare Conference
10. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
11. Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... , Oct. 17, 2014  Amgen (NASDAQ: ... Sanders Williams , M.D., president of Gladstone Institutes and ... "We are pleased to welcome Dr. ... Robert A. Bradway , chairman and chief executive ... in academic medicine and his direct experience in our ...
(Date:10/17/2014)... October 17, 2014 ... Market by Technique (Optical Coherence Tomography, Hyperspectral ... Application (Ophthalmology, Neurology, Oncology, Cardiology) - Global ... studies the Optical Imaging market over the ... valued at $917.1 million in 2014 and ...
(Date:10/17/2014)... Md. , Oct. 17, 2014 ... for Medical Technology Policy: The Green ... the FDA, public and private payers, medical device ... clinicians, and other experts January 12, 2015 at ... and value of weight loss treatments.  Participants will ...
Breaking Medicine Technology:Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Optical Imaging Market Worth $1,669.2 Million by 2019 2Optical Imaging Market Worth $1,669.2 Million by 2019 3Optical Imaging Market Worth $1,669.2 Million by 2019 4Green Park Collaborative to Discuss Comparative Effectiveness and Value of Weight Loss Treatments 2
... NEW YORK, Aug. 14 Immtech Pharmaceuticals,Inc. (Amex: ... paper published in Nucleic,Acids Research by a group ... ability of furamidine to inhibit a key enzyme ... Furamidine is the active metabolite (DB75),of Immtech,s proprietary, ...
... Scheduled Start of Phase 3 Clinical Trial, BELTSVILLE, ... has reported a second quarter 2007 loss from continuing,operations ... to a loss from,continuing operations of $699,000, or 5 ... from discontinued operations in the second quarter,of 2007 was ...
Cached Medicine Technology:Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 2Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms 3Spherix Reports Second Quarter Earnings 2
(Date:10/20/2014)... San Diego, CA (PRWEB) October 20, 2014 ... regarding all the latest information from the FDA on ... consumers on October 10 not to purchase or use Sit ... Phenolphthalein. Sit and Slim II is promoted as weight loss ... , Sibutramine, removed from the market in 2010 for safety ...
(Date:10/20/2014)... 20, 2014 National Teen Driver Safety Week ... American Academy of Pediatrics (Ohio AAP, http://www.ohioaap.org ) is ... parents of teen drivers to talk to their teens and ... Motor vehicle crashes are the leading cause of death for ... in fatal crashes, and 859 (42%) of those teen drivers ...
(Date:10/20/2014)... Houston, Texas (PRWEB) October 20, 2014 ... invited to present the key elements of his innovative ... visiting professor to plastic surgery residents and faculty at ... (UTMB) , where he, too, was once a medical ... of the largest private cosmetic plastic surgery practices in ...
(Date:10/19/2014)... UNITED NATIONS, New York (PRWEB) October 19, 2014 ... the United Nations Population Fund, welcomes news of a ... release of the more than 200 girls who were ... Girls. "These girls have languished in captivity long enough, ... their families, schools and communities," stated Dr. Osotimehin. , ...
(Date:10/19/2014)... October 20, 2014 SweetDressy.com, a professional ... announced its promotion for long evening dresses . ... the special offer; the current discount is up to ... the industry pioneers in the fashion field. Its dress ... ladies dwelling in various parts of the world. All ...
Breaking Medicine News(10 mins):Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:Promotion For Beautiful Long Evening Dresses Launched By SweetDressy.com 2
... the number of primary care physicians in medically underserved ... who often exhibit a strong sense of responsibility for ... new study by UCLA researchers and colleagues published in ... Public Health . Training these students ...
... By Steven Reinberg HealthDay Reporter , ... a booster shot of the vaccine that protects against ... The panel made the recommendation because the vaccine ... In 2007, the U.S. Centers for Disease Control ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Oct. ... the dangers associated with high blood pressure and many are ... known as hypertension, hasn,t changed in a decade, health officials ... the U.S. Centers for Disease Control and Prevention, 30 percent ...
... research published today, researchers uncover evolution in action in ... pancreatic tumours mean that not only is cancer genetically ... cancer spread within a patient has acquired distinct mutations. ... are ten different, but related, tumours. The complexity of ...
... Scientists are reporting development of a new approach for dealing ... simply mask odors like today,s room fresheners, but eliminates them ... from nanoparticles hundreds of times smaller than peach fuzz ... gold standard. A report on these next-generation odor-fighters appears in ...
... (HealthDay News) -- People who regularly eat whole grains rather ... fat linked to a higher risk for heart disease and ... visceral adipose tissue (VAT) -- the fat that surrounds the ... blood pressure, high cholesterol and insulin resistance, health risk factors ...
Cached Medicine News:Health News:Doctors' sense of mission, self-identity key in choice to work in underserved areas 2Health News:Teens Should Get Meningitis Booster Shot: CDC Panel 2Health News:Percentage of U.S. Adults With Hypertension Holds Steady at 30% 2Health News:Forces for cancer spread: Genomic instability and evolutionary selection 2Health News:Forces for cancer spread: Genomic instability and evolutionary selection 3Health News:Eating Whole Grains, Fewer Refined Grains, May Help Heart 2
Headlight module is mounted on UltraLite Plus headband....
... rapid rise in intracranial ... intervention and continuous monitoring. ... technology that gets to ... Its versatility makes it ...
The MPM-1 offers a broad range of functions to attain new levels of parenchymal and ventricular monitoring through fiberoptic technology at the source....
... Codman ICP Monitoring System ... of intracranial pressure at ... intraventricular levels. The information ... than through a hydrostatic ...
Medicine Products: